Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity

MLA

Shingo Kato, et al. “Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.” Frontiers in Immunology, vol. 9, Feb. 2018. EBSCOhost, https://doi.org/10.3389/fimmu.2018.00314.

APA

Shingo Kato, Jay A. Berzofsky, & Masaki Terabe. (2018). Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity. Frontiers in Immunology, 9. https://doi.org/10.3389/fimmu.2018.00314

Chicago

Shingo Kato, Jay A. Berzofsky, and Masaki Terabe. 2018. “Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.” Frontiers in Immunology 9 (February). doi:10.3389/fimmu.2018.00314.